Загрузка...
Efficacy and safety of homoharringtonine plus cytarabine and aclarubicin for patients with myelodysplastic syndrome-RAEB
The aim of the present study was to evaluate the treatment outcome of homoharringtonine, cytarabine (AraC) and aclarubicin combination therapy as induction treatment for myelodysplastic syndromes-refractory anemia with excess blasts (MDS-RAEB). A total of 24 patients with MDS-RAEB who were aged betw...
Сохранить в:
| Опубликовано в: : | Oncol Lett |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
D.A. Spandidos
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4727161/ https://ncbi.nlm.nih.gov/pubmed/26870217 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2015.3876 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|